Can-Fite BioPharma Ltd. SEC filings CANF
Can-Fite BioPharma Ltd. has 865 filings in SEC EDGAR's recent list, going back to Dec 1, 2011. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 9, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 25, 2026 | — |
| F-3/A | Amendment no. 1 to form f-3 | Sep 25, 2026 | — |
| POS AM | Post-effective amendment no. 11 to form f-1 | Sep 8, 2026 | — |
| POS AM | Post-effective amendment no. 11 to form f-1 | Sep 8, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 28, 2026 | — |
| 424B3 | Prospectus | Apr 3, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 31, 2026 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Mar 31, 2026 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Mar 31, 2026 | — |
| 424B3 | Prospectus | Mar 5, 2026 | — |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Sep 8, 2025 | — |
| POS AM | Post-effective amendment no. 7 to form f-1 | Aug 28, 2025 | — |
| POS AM | Post-effective amendment no. 7 to form f-1 | Aug 28, 2025 | — |
| 424B4 | Prospectus | Jul 29, 2025 | — |
| F-1/A | Amendment no. 1 to form f-1 | Jul 25, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jul 23, 2025 | — |
| 424B5 | Prospectus supplement | May 9, 2025 | — |
| 424B5 | Prospectus supplement | Apr 15, 2025 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Apr 14, 2025 | — |
| 424B3 | Prospectus | Sep 6, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 30, 2024 | — |
| POS AM | Post-effective amendment no. 7 to form f-1 | Aug 30, 2024 | — |
| 424B5 | Prospectus supplement | Aug 30, 2024 | — |
| 424B7 | Prospectus supplement | Jun 28, 2024 | — |
| S-8 | Employee stock plan registration | Apr 5, 2024 | — |
| POS AM | Post-effective amendment no. 6 to form f-1 | Apr 5, 2024 | — |
| F-3/A | Amendment no. 1 to form f-3 | Dec 28, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 12, 2023 | — |
| 424B3 | Prospectus | Nov 22, 2023 | — |
| POS AM | Post-effective amendment no. 5 to form f-1 | Sep 1, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 1, 2023 | — |
| POS AM | Post-effective amendment no. 4 to form f-1 | Apr 21, 2023 | — |
| S-8 | Employee stock plan registration | Apr 21, 2023 | — |
| POS AM | Post-effective amendment no. 3 to form f-1 | Mar 31, 2023 | — |
| 424B3 | Prospectus | Feb 10, 2023 | — |
| F-1/A | Amendment no. 1 to form f-1 | Feb 10, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Jan 31, 2023 | — |
| 424B3 | Prospectus | Jan 13, 2023 | — |
| 424B5 | Prospectus supplement | Jan 13, 2023 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Aug 26, 2022 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 25, 2022 | — |
| 424B3 | Prospectus | Jan 14, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 7, 2022 | — |
| 424B3 | Prospectus | Sep 1, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Aug 26, 2021 | — |
| POS AM | Post-effective amendment no. 3 to form f-1 | Aug 26, 2021 | — |
| 424B5 | Prospectus supplement | Aug 13, 2021 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Apr 5, 2021 | — |
| F-6EF | Filing | Nov 6, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 25, 2020 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Aug 28, 2020 | — |
| 424B3 | Prospectus | Jul 24, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jul 10, 2020 | — |
| 424B5 | Prospectus supplement | Jul 8, 2020 | — |
| 424B5 | Prospectus supplement | Jun 12, 2020 | — |
| 424B3 | Prospectus | Jun 1, 2020 | — |
| 424B3 | Prospectus | Apr 7, 2020 | — |
| 424B3 | Prospectus | Apr 7, 2020 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Apr 6, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Mar 27, 2020 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 27, 2020 | — |
| 424B4 | Prospectus | Feb 12, 2020 | — |
| F-1/A | Amendment no. 2 to form f-1 | Feb 10, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Feb 3, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jan 24, 2020 | — |
| 424B3 | Prospectus | Jan 10, 2020 | — |
| 424B3 | Prospectus | Jan 10, 2020 | — |
| 424B3 | Prospectus | Oct 18, 2019 | — |
| F-1/A | Amendment no. 4 to form f-1 | Oct 18, 2019 | — |
| F-1/A | Amendment no. 3 to form f-1 | Oct 17, 2019 | — |
| F-1/A | Amendment no. 2 to form f-1 | Jul 12, 2019 | — |
| F-1/A | Amendment no. 2 to regitration statement | Jun 28, 2019 | — |
| F-1/A | Amendment no. 1 to registration statement | May 28, 2019 | — |
| 424B5 | Prospectus supplement | May 22, 2019 | — |
| F-1 | Registration statement (foreign issuer) | May 3, 2019 | — |
| 424B5 | Prospectus supplement | Apr 4, 2019 | — |
| 424B3 | Prospectus | Mar 22, 2019 | — |
| F-1/A | Amendment no. 1 to form f-1 | Mar 12, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Feb 15, 2019 | — |
| 424B5 | Prospectus supplement | Jan 22, 2019 | — |
| S-8 | Employee stock plan registration | Oct 9, 2018 | — |
| 424B3 | Prospectus | Sep 13, 2018 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Aug 31, 2018 | — |
| F-1/A | Post-effective amendment no. 1 to form f-1 | Aug 31, 2018 | — |
| F-1 | Registration statement (foreign issuer) | Aug 8, 2018 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Mar 29, 2018 | — |
| 424B5 | Prospectus supplement | Mar 12, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 26, 2017 | — |
| 424B3 | Prospectus | Sep 15, 2017 | — |
| 424B3 | Prospectus | Jun 14, 2017 | — |
| F-1 | Registration statement (foreign issuer) | May 30, 2017 | — |
| 424B5 | Prospectus supplement | Jan 20, 2017 | — |
| 424B3 | Prospectus | Jun 28, 2016 | — |
| 424B3 | Prospectus | Jan 29, 2016 | — |
| 424B3 | Prospectus | Jan 19, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 19, 2016 | — |
| 424B5 | Prospectus supplement | Oct 15, 2015 | — |
| 424B3 | Prospectus | Oct 2, 2015 | — |
| 424B5 | Prospectus supplement | Sep 22, 2015 | — |
| 424B3 | Prospectus | Jun 23, 2015 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 8, 2015 | — |
| 424B5 | Prospectus supplement | Dec 4, 2014 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 30, 2014 | — |
| 424B3 | Prospectus | Sep 30, 2014 | — |
| POS AM | Post-effective amendment no. 1 | Sep 17, 2014 | — |
| 424B3 | Prospectus | Apr 24, 2014 | — |
| F-1 | Registration statement (foreign issuer) | Apr 8, 2014 | — |
| F-6 POS | Post effective amendment no. 1 to the form f-6 | Aug 21, 2013 | — |
| 424B3 | Prospectus | May 13, 2013 | — |
| F-6 | Form f-6 | Sep 6, 2012 | — |
Showing 115 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CANF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ramat Gan, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1536196
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.